Management of patients who have “Eating and Drinking with Acknowledged Risk” decision made during hospital stay - QI

Abstract ID
4462
Authors' names
Đula Alićehajić-Bečić (Consultant Pharmacist Frailty), Feruza Soxibova (Junior Clinical Fellow), Rachel Doran (Lead Speech and Language Therapist), Sophie Price (CMT1 Surgery)
Author's provenances
Wrightington, Wigan and Leigh NHS Teaching Trust
Abstract category
Abstract sub-category

Abstract

Introduction:

Eating and Drinking with Acknowledged Risks is an individualised clinical decision balancing risks (may refer to aspiration, malnutrition, dehydration and choking) and benefits (quality of life, pleasure of eating). It may be applied in patients who have irreversible swallowing difficulty, with swallow reflex present where alternative means of providing nutrition are not appropriate.

Method:

Previous work completed in 2023 looked at cohort of patients where “Eating and Drinking with acknowledged risk” decision was made on Ageing and Complex Medicine ward over 12month period (n=22). Adaptations to process were made following on from this in addition to education sessions and data re-gathered in 2025 from Speech and Language referral orders to evaluate current issues with management (n=27) from across the hospital.

Results:

Overall little improvement was observed in patients who lacked capacity with only 11.5% of the cohort having all four critical points addressed in a Best Interest Meeting discussion in 2025 and variable compliance across four core outcomes 2023 vs 2025 (risks 55% vs 69%, irreversibility 32% vs 58%, not suitable for NG/PEG 64% vs 61% and best option for quality of life 86% vs 65%). Same rate of 22% readmissions was observed across both cohorts despite advanced care planning completion improvement from 22% in 2023 to 50% in 2025.

Conclusions:

We have observed little improvement in the two cohorts analysed. A system change which encapsulates important considerations for EDAR discussions will be built on our clinical informatics system to address this.

Comments

Really important work, I like how you’ve highlighted the complexity of EDAR decisions, especially around balancing safety with quality of life.

I was wondering, do you think the limited improvement reflects challenges in capturing genuinely patient-centred decision-making, rather than just completing the four criteria?

And building on that, how do you ensure that Best Interest discussions are truly reflective of patient values, rather than being clinician-led or risk-driven?

So in that context, how will your system change support better shared decision-making and patient-centred outcomes, not just improved documentation?

Submitted by islam1048@gmail.com on

Permalink

I was wondering if the EDAR decision have any impact on medicines administration or did it prompt medication review? If not would there be plans to study this further as an opportunity to promote deprescribing in this group? Thanks

Submitted by jennifer.crawf… on

Permalink

This poster highlights the importance of MDT working in patient care. When these decisions are made, what do you do about patients regular medications? Should it be part of Advance care planning?

Submitted by punam.sinha_14507 on

Permalink